Syngene International Limited (SYNGENE.NS) Seasonal Returns Chart - Yahoo Finance
NiveshIQ
NSE: SYNGENE · Healthcare
Syngene International Ltd.
₹412.95▲ ₹10.25 (+2.55%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SYNGENE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Syngene International Ltd.
Syngene International Limited is a contract research and manufacturing organization that delivers end‑to‑end drug discovery and development services across India, the United States, Europe and other international markets. Its core revenue drivers include discovery chemistry and biology services, preclinical development, and clinical trial management, with a recent expansion of its integrated platform and the first agreement secured by Bayview. In FY27 Q2, revenue rose 13% sequentially to ₹3,600 Cr, but net profit fell 52% YoY to ₹221 Cr due to lower Zoetis revenue and significant foreign‑exchange hedge losses. The company’s EBITDA margin improved, reflecting better cost control and higher-margin service mix. Competitive positioning is strengthened by a diversified portfolio of synthetic, m
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,489 Cr +9.26% | ₹3,642 Cr +4.41% | ₹3,739 Cr +2.64% |
| EBITDA Margin | 29.08% | 28.60% | 24.57% |
| Net Profit | ₹510.00 Cr +9.82% | ₹496.20 Cr -2.71% | ₹316.70 Cr -36.17% |
| EPS | ₹12.71 | ₹12.35 | ₹7.87 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Analyst Estimates: Here's What Brokers Think Of Syngene International Limited (NSE:SYNGENE) After Its Second-Quarter Report
Syngene International Q2 FY27 Results Newspaper Publication
🔒
+ 3 more stories about Syngene International Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹833 Cr, PAT ₹32 Cr, EPS ₹0.80, EBITDA margin 17.7%. Growth context: revenue YoY -8.6%, PAT YoY -52.0%, revenue QoQ +13.1%, PAT QoQ -457.8%.
Recent corporate activity highlights geographic expansion and international growth as the primary near-term growth lever...
FY26 (last completed FY): revenue ₹3, 739 Cr, PAT ₹317 Cr, EBITDA margin 24.6%, EPS ₹7.87. Year-on-year: revenue YoY +2....
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Shilpa Medicare Ltd.Strides Pharma Science Ltd.Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.Supriya Lifescience Ltd.Suven Life Sciences Ltd.Thyrocare Technologies Ltd.Torrent Pharmaceuticals Ltd.Ventive Hospitality Ltd.Vijaya Diagnostic Centre Ltd.Viyash Scientific Ltd.Wockhardt Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SYNGENE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SYNGENE alongside your other holdings
Unlock full SYNGENE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Syngene International Ltd.?
NiveshIQ detects active intelligence signals for Syngene International Ltd. (SYNGENE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Syngene International Ltd.?
Syngene International Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,851,528.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.